Research Summary

Dr. Chiung-Yu Huang is a Professor of Biostatistics at the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF) and serves as an Adjunct Professor at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center. Dr. Huang is a Fellow of the American Statistical Association (ASA) and Institute of Mathematical Statistics (IMS). She is well known for her contributions to methodology research, particularly in the areas of survival analysis, competing risks analysis, recurrent event analysis, outcome-dependent sampling, and the design and evaluation of vaccine efficacy trials.

Dr. Huang's recent work has focused on developing innovative statistical methodologies to improve analysis efficiency in small-scale studies by integrating external large databases, modeling and predicting the risk of recurrent events to identify high-risk individuals, and incorporating information on infecting pathogens in the analysis of vaccine trials with active or passive surveillance. Additionally, she has developed efficient statistical methods for analyzing survival data collected in prevalent cohort studies, benefit-risk assessment tools for evaluating treatment risks and benefits in patients with end-stage disease, and statistical methods that can account for informative clinic visits in the analysis of electronic health records.

In addition to her methodological research, Dr. Huang has extensive experience in collaborative research across a wide range of fields, including influenza, malaria, transplant, and cancer studies. During her tenure as a Mathematical Statistician at the National Institute of Allergy and Infectious Diseases (NIAID), she collaborated with both extramural and intramural scientists on the design, conduct, monitoring, analysis, and presentation of preclinical and clinical studies. She also served as a statistician to the NIAID Influenza Research Collaboration (NIRC) and the Mexican Emerging Infectious Disease Clinical Research Network (La Red), and received numerous awards for her collaborative research, including the prestigious NIAID Merit Award.

Since joining UCSF in 2017, Dr. Huang has served as the lead statistician for the Hematopoietic Malignancies Program at UCSF Helen Diller Family Comprehensive Cancer Center and the University of California Hematologic Malignancies Consortium (UCHMC). She also established and served as the core director of the UCSF Department of Surgery Biostatistics Research Core (2019-2024), which provides statistical support to surgery investigators in designing and conducting rigorous, high-quality research.

Research Funding

  • September 1, 2024 - August 31, 2029 - Improving causal inference in Alzheimer's Disease prevention research on modifiable risk factors: the Triangulation of Innovative Methods to End AD (TIME-AD) project , Co-lead of Analytics Core . Sponsor: NIH/NIA, Sponsor Award ID: P01AG082653
  • August 1, 2025 - May 31, 2029 - Statistical Methods for Information Synthesizing Using Multiple Existing Longitudinal Cohort Studies , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01HL173153
  • September 1, 2023 - May 31, 2028 - Cancer Center Support Grant – Biostatistics & Population Research Shared Resource , Co-Investigator . Sponsor: NIH/NCI, Sponsor Award ID: P30CA082103
  • June 15, 2018 - May 31, 2028 - The spectrum of cognitive impairment including Alzheimer?s Disease and Related Dementias after liver transplantation , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01AG059183
  • August 5, 1999 - May 31, 2028 - Cancer Center Support Grant , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P30CA082103
  • August 1, 2022 - July 31, 2027 - The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation , Co-Investigator . Sponsor: NIH/NHLBI, Sponsor Award ID: U01HL163242
  • September 1, 2022 - August 31, 2025 - CF Statistical Expertise and Network (CF StatNet) Award , Statistician . Sponsor: Cystic Fibrosis Foundation, Sponsor Award ID: CFStatNet 003789Y7122
  • November 1, 2021 - January 31, 2025 - Mixed Data Meta-analysis: Integration of Individual Participant and Aggregate Data , Co-Investigator . Sponsor: PCORI, Sponsor Award ID: ME-2020C3-21269
  • June 1, 2018 - May 31, 2023 - UCSF Liver Core Center, Biostatistics Core , Statistician . Sponsor: NIH/NIDDK, Sponsor Award ID: P30DK026743
  • September 1, 2021 - January 31, 2023 - Allergy, Immunology and Transplantation Research (UCSF Coordinating Center) , Statistician . Sponsor: NIH/NIAID, Sponsor Award ID: 3UM1AI109565-08S3
  • September 1, 2019 - July 31, 2022 - A novel natural history study of medullary thyroid carcinoma , Statistician . Sponsor: University of Texas M.D. Anderson Cancer Center, Sponsor Award ID: R01FD006650
  • July 1, 2015 - June 30, 2021 - Statistical Methods for Survival and Recurrent Event Data in Clinical Research , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA193888
  • July 1, 2015 - June 30, 2020 - Reprogramming the pancreatic tumor microenvironment with immunotherapy , Statistician/Principal Investigator (Subaward) . Sponsor: NIH/NCI, Sponsor Award ID: R01CA197296
  • September 1, 2017 - December 31, 2018 - Comparing Patient Centered Outcomes in the Management of Pain between Emergency Departments and Dedicated Acute Care Facilities for Adults with Sickle Cell disease , Statistician/Principal Investigator (Subaward) . Sponsor: PCORI, Sponsor Award ID: HIS-1403-11888

Education

National Tsing-Hua University, Hsinchu, Taiwan, B.S., 07/1994, Mathematics
National Tsing-Hua University, Hsinchu, Taiwan, M.S., 07/1996, Mathematics
Johns Hopkins University, Baltimore, Maryland, Ph.D., 05/2002, Biostatistics

Honors & Awards

  • Frank Wilcoxon Award, American Society for Quality, 2025
  • Elected Fellow, Institute of Mathematical Statistics, 2025
  • Y.S. Chow Distinguished Lecture Award, Chinese Institute of Probability and Statistics, 2022
  • Elected Fellow, American Statistical Association, 2018
  • Distinguished Alumni Award, National Tainan Girls' Senior High School, Tainan, Taiwan, 2017
  • NIH Merit Award, National Institute of Allergy and Infectious Diseases, Bethesda, MD, 2007
  • Margaret Merrell Award, Department of Biostatistics, Johns Hopkins University, Baltimore, MD, 2002

Selected Publications

  1. Zanwar S, Hansen D, Pasvolsky O, Tan C, Peres L, Goel U, Popat R, Afrough A, Asoori S, Rana M, Dave M, Portuguese A, Kastritis E, Davis JA, Martinez-Lopez J, Sborov D, Hájek R, Bal S, Janakiram M, Pan D, Shune L, Ferreri C, Biran N, Herr M, Hassan H, Grajales-Cruz A, Khouri J, De Menezes Silva Corraes A, Kort J, Atrash S, Castaneda Puglianini O, Baz R, Cassano Cassano R, Liang EC, Zolotov E, Ali HM, Varga C, Richards T, Hosoya H, Gaballa M, Dillard C, Galarza Fortuna G, Lee L, Julian K, Green K, Sannareddy A, Anderson LD Jr, Alsina M, Raza S, Dima D, Mikkilineni L, Anwer F, Banerjee R, Krishnan A, Dhakal B, Locke FL, Voorhees P, Kumar S, Usmani S, Huang CY, Mian H, Sidana S, Patel K, Martin T, Lin Y, Costa L. Early treatment failure in patients with relapsed/refractory multiple myeloma receiving bispecific T-cell engagers: Development and validation of the CHARGE prognostic index. Journal of Clinical Oncology. 2026. View on PubMed
  2. Marr KA, Vanbiervliet Y, Permpalung N, Huang CY, Aerts R, Baburina I, Marques PX, Shorr AF, Nguyen MHT, Hao B, Wingard JR, Maertens J, Zhang S. . Performance of the urinary MycoMEIA Aspergillus assay as an aid to diagnose invasive Aspergillosis. Clinical Infectious Diseases. Clinical Infectious Diseases. 2026. View on PubMed
  3. Janakiram M, Tan CR, Mian H, Huang CY, Popat R, Martínez-Lopez J, Kastritis E, Chng WJ, Kapoor P, Dave M, Bal S, Garderet L, Corraes AMS, Riedhammer C, Steinbrunn T, Corona M, Nagarajan C, Einsele H, Martin T, Krishnan A, Lin Y. Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis. Am J Hematol. 2026 Aug; 101(8):1928-1937. View on PubMed
  4. Huang Y, Kim HJ, Huang CY, Kim MO. Bayesian random-effects meta-analysis integrating individual participant data and aggregate data. Journal of the American Statistical Association. 2025; 120(552):2128–2139. View on PubMed
  5. Qin J, Liu Y, Li M, Huang CY. Distribution-free prediction intervals under covariate shift, with an application to causal inference. Journal of the American Statistical Association. 2025; 120(549):559-571. View on PubMed
  6. Lai M, Fenton C, Rubin J, Huang CY, Pletcher M, Lai JC, Cullaro G, Ge J. Clinical Sentiment Analysis by Large Language Models Enhances Prediction of Hepatorenal Syndrome. Gastro Hep Adv. 2025; 4(10):100797. View on PubMed
  7. Sun Y, Chiou SH, Huang CY. Global and Episode-Specific Prediction of Recurrent Events Using Longitudinal Health Informatics Data. J Am Stat Assoc. 2025 Jul 03. View on PubMed
  8. Gutierrez SA, Raghu V, Oliveira SB, Nguyen V, Shui AM, Sudan DL, Cole C, Huang CY, Rhee S, Lai JC, Wadhwani SI. Central line-associated bloodstream infection rates in pediatric short bowel syndrome in the United States: A retrospective cohort study from 2016 to 2023. JPEN J Parenter Enteral Nutr. 2025 Jul; 49(5):572-579. View on PubMed
  9. Ge J, Lee A, Gologorskaya O, Far AT, Bastani A, Huang CY, Pletcher MJ, Lai JC. Characterizing practice variations in the care of hospitalized patients with cirrhosis across the University of California Health. Liver Transpl. 2026 Mar 01; 32(3):346-356. View on PubMed
  10. Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Denbow R, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Winer EP, Krop IE, Wolff AC, Wahl RL, Perez EA, Huang CY, Stearns V, Thompson EA, Connolly RM. Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response. JCO Precis Oncol. 2025 Apr; 9:e2400546. View on PubMed
  11. Tan CR, Asoori S, Huang CY, Brunaldi L, Popat R, Kastritis E, Martinez-Lopez J, Bansal R, Silva Corraes AM, Chhabra S, Parrondo R, Ailawadhi S, Fotiou D, Dimopoulos MA, Yong K, Mactier C, Lau C, Corona M, Marin AJS, Mian H, Durie BG, Usmani SZ, Martin TG, Lin Y. Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study. Blood Cancer J. 2025 04 03; 15(1):53. View on PubMed
  12. Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Vaklavas C, Krop I, Winer E, Denbow R, Valero V, Wolff AC, Wahl RL, Huang CY, Stearns V, Thompson EA, Connolly RM. A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026). Breast. 2025 Jun; 81:104432. View on PubMed
  13. Prather AA, Gao Y, Betancourt L, Kordahl RC, Sriram A, Huang CY, Hays SR, Kukreja J, Calabrese DR, Venado A, Kapse B, Greenland JR, Singer JP. Disturbed sleep after lung transplantation is associated with worse patient-reported outcomes and chronic lung allograft dysfunction. JHLT Open. 2025 Feb; 7:100170. View on PubMed
  14. Far AT, Bastani A, Lee A, Gologorskaya O, Huang CY, Pletcher MJ, Lai JC, Ge J. Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4. Hepatology. 2025 Jun 01; 81(6):1753-1763. View on PubMed
  15. Seijo L, Gao Y, Betancourt L, Venado A, Hays SR, Kukreja J, Calabrese DR, Greenland JR, Singer JP. Improvements in Patient-Reported Functioning after Lung Transplant is Associated with Improved Quality of Life and Survival. medRxiv. 2024 Aug 06. View on PubMed
  16. Szabo Yamashita T, Williams-Perez SM, Ehsan S, Mulder M, Kronenfeld D, Huang CY, Zhao H, Merriman K, Peterson SK, Hu MI, Zafereo M, Sosa JA, Grubbs EG. The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population? Thyroid. 2024 09; 34(9):1117-1125. View on PubMed
  17. Wang M, Chiou SH, Ganger D, Ruck J, Huang CY, Kappus MR, King EA, Ladner DP, Rahimi RS, Duarte-Rojo A, Volk ML, Tevar AD, Verna EC, Lai JC. Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 2025 Apr 01; 81(4):1269-1275. View on PubMed
  18. Wang M, Shui AM, Huang CY, Kappus MR, Rahimi R, Verna EC, Ruck J, King EA, Ladner DP, Tevar AD, Volk ML, Duarte-Rojo A, Ganger D, Lai JC. The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone. Liver Transpl. 2024 Dec 01; 30(12):1326-1329. View on PubMed
  19. Sheng Y, Sun Y, McCulloch CE, Huang CY. Scalable estimation for high velocity survival data able to accommodate adding covariates. Statistica Sinica. 2024; 3(34):1483-1503. View on PubMed
  20. Sheng Y, Qin J, Huang CY. Sequential data integration under dataset shift. Technometrics. 2024; 66(4):662–670. View on PubMed

Go to UCSF Profiles, powered by CTSI